Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miRNAs from Inflamed Gingiva Link Gene Signaling to Increased MET Expression.

Journal of dental research·2023
Same author

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

The Lancet. Infectious diseases·2022
Same author

BACH1 Binding Links the Genetic Risk for Severe Periodontitis with <i>ST8SIA1</i>.

Journal of dental research·2021
Same author

<i>Entamoeba gingivalis</i> Exerts Severe Pathogenic Effects on the Oral Mucosa.

Journal of dental research·2021
Same author

History of BCG Vaccination Recommendations in East and West Germany from 1951 to Date.

Pneumologie (Stuttgart, Germany)·2020
Same author

[DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].

Pneumologie (Stuttgart, Germany)·2020

Related Experiment Video

Updated: May 19, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Enabling biomarkers for tuberculosis control.

J Maertzdorf1, J Weiner, S H E Kaufmann

  • 1Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|August 9, 2012
PubMed
Summary

Biomarkers for tuberculosis (TB) can accelerate diagnosis and treatment. Advanced profiling platforms like transcriptomics, proteomics, and metabolomics show promise for identifying high-risk individuals and improving clinical trials.

More Related Videos

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Related Experiment Videos

Last Updated: May 19, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Area of Science:

  • * Biomedical science
  • * Molecular biology
  • * Computational biology

Background:

  • * Accelerated control of tuberculosis (TB) necessitates improved diagnostic and prognostic tools.
  • * Biomarkers are crucial for rapid diagnosis, risk stratification of latent infections, and efficient clinical trials for new TB drugs and vaccines.
  • * Current TB control measures require enhancement through advanced biomarker discovery.

Purpose of the Study:

  • * To review global biomarker profiling platforms for TB: transcriptomics, proteomics, and metabolomics.
  • * To highlight recent advancements in biomarker research for TB diagnosis and progression prediction.
  • * To emphasize the role of computational analysis in interpreting complex biomarker data.

Main Methods:

  • * Review of transcriptomics, proteomics, and metabolomics platforms for biomarker discovery.
  • * Analysis of data from global biomarker profiling studies.
  • * Discussion of computational approaches for biomarker data analysis.

Main Results:

  • * Biomarker platforms offer potential for rapid TB diagnosis and risk assessment.
  • * Transcriptomics, proteomics, and metabolomics are key technologies in TB biomarker research.
  • * Computational analyses are essential for leveraging biomarker data effectively.
  • * Biosignatures to differentiate active TB are anticipated within a decade.

Conclusions:

  • * Biomarkers can significantly advance TB control by enabling precise diagnosis and personalized interventions.
  • * While sophisticated biosignatures are expected, simple point-of-care diagnostics for TB may take longer to develop.
  • * Biomarker research provides insights into TB pathogenesis, paving the way for novel therapeutic targets.